ES475509A1 - Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae. - Google Patents

Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae.

Info

Publication number
ES475509A1
ES475509A1 ES475509A ES475509A ES475509A1 ES 475509 A1 ES475509 A1 ES 475509A1 ES 475509 A ES475509 A ES 475509A ES 475509 A ES475509 A ES 475509A ES 475509 A1 ES475509 A1 ES 475509A1
Authority
ES
Spain
Prior art keywords
preparation
pneumococcal vaccine
streptococcus pneumoniae
capsular polysaccharide
capsular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES475509A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES475509A1 publication Critical patent/ES475509A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1. Esta invención proporciona una vacuna eficaz contra uno o más tipos de strepcoccus pneumoniae, que comprende uno o más polisacáridos capsulares altamente purificados de Streptococcus pneumoniae. Cada polisacárido capsular se prepara cultivando el organismo productos de ese polisacárido capsular, en condiciones controladas de pH y reponiendo la concentración de glucosa durante la fermentación.
ES475509A 1977-11-28 1978-11-28 Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae. Expired ES475509A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85549177A 1977-11-28 1977-11-28

Publications (1)

Publication Number Publication Date
ES475509A1 true ES475509A1 (es) 1980-07-16

Family

ID=25321387

Family Applications (1)

Application Number Title Priority Date Filing Date
ES475509A Expired ES475509A1 (es) 1977-11-28 1978-11-28 Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae.

Country Status (13)

Country Link
EP (1) EP0002404A1 (es)
JP (1) JPS5495724A (es)
AU (1) AU529128B2 (es)
CA (1) CA1115210A (es)
DK (1) DK527078A (es)
ES (1) ES475509A1 (es)
FI (1) FI783620A7 (es)
IT (1) IT1109450B (es)
NO (1) NO783976L (es)
NZ (1) NZ188966A (es)
PT (1) PT68831A (es)
YU (1) YU283378A (es)
ZA (1) ZA786664B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
US4287173A (en) * 1979-09-24 1981-09-01 Merck & Co., Inc. Vaccine for dental caries
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
BE889979A (fr) * 1981-08-14 1982-02-15 Smith Kline Rit Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
NL8202527A (nl) * 1982-06-22 1984-01-16 Univ Utrecht Vaccins tegen door bacterien met kapsel-polysacchariden verwekte ziekten en werkwijze voor het bereiden daarvan.
US4686102A (en) * 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
CA2604363C (en) 2005-04-08 2015-06-16 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
NZ562719A (en) 2005-04-08 2008-12-24 Wyeth Corp Separation of contaminants from streptococcus pneumoniae polysaccharide by pH manipulation
PT2129693T (pt) * 2007-03-23 2017-02-14 Wyeth Llc Processo de purificação abreviado para a produção de polissacáridos capsulares de streptococcus pneumoniae
KR20110091546A (ko) 2008-12-18 2011-08-11 와이어쓰 엘엘씨 스트렙토코커스 뉴모니에 혈청형 19ａ 폴리사카라이드 분자량을 조절하는 방법
ES2749952T3 (es) 2008-12-18 2020-03-24 Wyeth Llc Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
WO2012150861A1 (en) * 2011-05-02 2012-11-08 Stichting Top Institute Food And Nutrition Probiotics with enhanced survival properties
CN106460062A (zh) 2014-05-05 2017-02-22 美敦力公司 用于scd、crt、crt‑d或sca治疗识别和/或选择的方法和组合物
CN114853917A (zh) * 2022-04-22 2022-08-05 兰州生物制品研究所有限责任公司 制备肺炎球菌荚膜多糖和肺炎球菌疫苗的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires

Also Published As

Publication number Publication date
FI783620A7 (fi) 1979-05-29
CA1115210A (en) 1981-12-29
EP0002404A1 (en) 1979-06-13
AU529128B2 (en) 1983-05-26
YU283378A (en) 1983-04-30
IT7852075A0 (it) 1978-11-27
AU4172878A (en) 1979-06-07
ZA786664B (en) 1980-07-30
NO783976L (no) 1979-05-29
JPS5495724A (en) 1979-07-28
PT68831A (en) 1978-12-01
DK527078A (da) 1979-07-04
IT1109450B (it) 1985-12-16
NZ188966A (en) 1982-03-23

Similar Documents

Publication Publication Date Title
ES475509A1 (es) Un metodo de preparacion de una vacuna polivalente eficaz contra el streptococcus pneumoniae que comprende polisacari-dos capsulares altamente purificados de estreptococcus pneu-moniae.
AU1258176A (en) Method forthe cultivation of microorganisms from body fluid
CA979805A (en) Method for isolation of antithrombin from animal tissue material by adsorption on sulfated carbohydrate gel
UA6025A1 (uk) Спосіб одержання факторів 1,2,3,4,5 тейхоміціна а та їх солей 2
PT70610A (fr) Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient
ATE71113T1 (de) Antibiotikum a 40926 mannosyl aglycon.
GB1469862A (en) Therapeutic compositions containing etherified monosaccharide derivatives and method of using the same
FR2407262A1 (fr) Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits
FR2388563A1 (fr) Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
ES8101645A1 (es) Un procedimiento para la produccion de heteropolisacarido s-60
GB1385095A (en) Dental plaque reducing enzymes and their preparation
NO160011C (no) Mikrobiologisk fremgangsmaate for fremstilling av antracyklin-derivater.
ES412098A1 (es) Procedimiento para la produccion de inhibidores de sacara- sa.
ES443983A1 (es) Implemento para el cultivo y fertilizacion de la cana de a- zucar.
ES418743A1 (es) Un procedimiento para la preparacion del complejo antibio- tico de la butirosina.
FR2183192B1 (es)
NO810778L (no) Homositronsyre oligoriboside-derivater, fremgangsmaate for deres fremstilling og deres bruk for aa forebygge dental karries
IT1189224B (it) Sostanze carcinostatiche ed immunostimolanti tf-2,procedimento per prepararle ed agente carcinostatico che le contiene
GB1300694A (en) Biocidal composition and disinfecting method
BR7304936D0 (pt) Composicao pigmentada de nylon, formadora de fibra, estabilizada contra os efeitos de gradantes de radiacao actenica e da acao do tempo
SE8005921L (sv) Nya foreningar med karcinostatisk och immunostimulerande aktivitet samt forfarande for framstellning derav
DK411584D0 (da) Antibiotikum sb 22484, fremgangsmaade til fremstilling deraf og mikroorganisme med evne til at danne det
SE7902005L (sv) Nytt forfarande for framstellning av cefamycin c
GB1324968A (en) Process for the preparation of 15,16,-diacetyl-digoxin
GB1330805A (en) Immunization methods against toxic effects of bacterial infection